Reata Pharmaceuticals ~ Manmeet Soni
Reata Pharmaceuticals (NASDAQ: RETA) $2.33b Manmeet Soni (PwC) named CFO x- Alnylam Pharmaceuticals CFO succeeds Jason Wilson continues as EVP Ops
$$$$ Base salary $530,000; Sign-on $150,000; Bonus 40% of base; Equity stock option to purchase 250,000 & 50,000 shares